Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival

Breast Cancer Research and Treatment

Volumn 143, Issue 2, 2014, Pages 277-286

  Auvinen, Päivi ^a   Rilla, Kirsi ^b   Tumelius, Ritva ^b   Tammi, Markku ^b   Sironen, Reijo ^a,b   Soini, Ylermi ^a,b   Kosma, Veli Matti ^a,b   Mannermaa, Arto ^a,b   Viikari, Jukka ^b   Tammi, Raija ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Breast cancer; HER2; Hyaluronan synthase; Obesity

Indexed keywords

ESTROGEN RECEPTOR; HERMES ANTIGEN; HYALURONAN SYNTHASE 1; HYALURONAN SYNTHASE 2; HYALURONAN SYNTHASE 3; HYALURONIC ACID; SYNTHETASE; UNCLASSIFIED DRUG; CD44 PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; GLUCURONOSYLTRANSFERASE; HAS1 PROTEIN, HUMAN; HAS2 PROTEIN, HUMAN; HAS3 PROTEIN, HUMAN; MESSENGER RNA; MONOCLONAL ANTIBODY; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; OBESITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TUMOR VOLUME; VERY ELDERLY; BIOSYNTHESIS; BREAST NEOPLASMS; CLASSIFICATION; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, CD44; BREAST NEOPLASMS; FEMALE; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; OBESITY; RECEPTOR, ERBB-2; RNA, MESSENGER; STROMAL CELLS; SURVIVAL; SURVIVAL ANALYSIS;

EID: 84893666005     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2804-7     Document Type: Article

References (39)

1. Tammi R, Kultti A, Kosma VM, Pirinen R, Auvinen P, Tammi M (2008) Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin Cancer Biol 18:288-295
2. Auvinen P, Tammi R, Parkkinen J, Tammi M, Ågren U, Johansson R, Hirvikoski P, Eskelinen M, Kosma VM (2000) Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 156:529-536
3. Weigel P, DeAngelis P (2007) Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J Biol Chem 282:36777-36781
4. Camenisch T, Spicer A, Brehm-Gibson T, Biesterfeldt J, Augustine M, Calabro A Jr, Kubalak S, Klewer S, McDonald J (2000) Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 106:349-360
5. Tammi R, Passi A, Rilla K, Karousou E, Vigetti D, Makkonen K, Tammi M (2011) Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J 278:1419-1428
6. Tammi R, MacCallum D, Hascall V, Pienimäki J, Hyttinen M, Tammi M (1998) Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides. J Biol Chem 273:28878-28888
7. Evanko S, Tammi M, Tammi R, Wight T (2007) Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev 59:1351-1365
8. Rilla K, Siiskonen H, Spicer A, Hyttinen J, Tammi M, Tammi R (2005) Plasma membrane residence of hyaluronan synthase is coupled to its enzymatic activity. J Biol Chem 280:31890-31897
9. Kultti A, Pasonen-Seppänen S, Jauhiainen M, Rilla KJ, Kärnä R, Pyöriä E, Tammi R, Tammi M (2009) 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp Cell Res 315:1914-1923
10. Kramer M, Escudero D, Lokeshwar S, Golshani R, Ekwenna O, Acosta K, Merseburger A, Soloway M, Lokeshwar V (2011) Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis. Cancer 117:1197-1209
11. Chi A, Shirodkar S, Escudero D, Ekwenna O, Yates T, Ayyathurai R, Garcia-Roig M, Gahan J, Manoharan M, Bird V, Lokeshwar V (2012) Molecular characterization of kidney cancer: association of hyaluronic acid family with histological subtypes and metastasis. Cancer 118:2394-2402
12. Yamada Y, Itano N, Narimatsu H, Kudo T, Morozumi K, Hirohashi S, Ochiai A, Ueda M, Kimata K (2004) Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer. Clin Exp Metastasis 21:57-63
13. Yabushita H, Noguchi M, Kishida T, Fusano K, Noguchi Y, Itano N, Kimata K, Noguchi M (2004) Hyaluronan synthase expression in ovarian cancer. Oncol Rep 12:739-743
14. Nykopp T, Rilla K, Tammi MI, Tammi RH, Sironen R, Hämälä inen K, Kosma VM, Heinonen S, Anttila M (2010) Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma. BMC Cancer 10:512
15. Udabage L, Brownlee G, Waltham M, Blick T, Walker E, Heldin P, Nilsson S, Thompson E, Brown T (2005) Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res 65:6139-6150
16. Okuda H, Kobayashi A, Xia B, Watabe M, Pai SK, Hirota S, Xing F, Liu W, Pandey P, Fukuda K, Modur V, Ghosh A, Wilber A, Watabe K (2012) Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Cancer Res 72:537-547
17. Auvinen P, Tammi R, Kosma VM, Sironen R, Soini Y, Mannermaa A, Tumelius R, Uljas E, Tammi M (2013) Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer. Int J Cancer 132:531-539
18. Törrönen K, Nikunen K, Kärnä R, Tammi M, Tammi R, Rilla K (2013) Tissue distribution and subcellular localization of hyaluronan synthase isoenzymes. Histochem Cell Biol. doi: 10.1007/s00418-013-1143-4
19. Tammi R, Ågren U, Tuhkanen A, Tammi M (1994) Hyaluronan metabolism in skin. Prog Histochem Cytochem 29:1-81
20. McShane L, Altman D, Sauerbrei W, Taube S, Gion M, Clark G, Statistics Subcommittee of NCI-EORTC Working Group on Cancer Diagnostics (2006) Reporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 100:229-235
21. Bharadwaj A, Kovar J, Loughman E, Elowsky C, Oakley G, Simpson M (2009) Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing. Am J Pathol 174:1027-1036
22. Itano N, Kimata K (2008) Altered hyaluronan biosynthesis in cancer progression. Semin Cancer Biol 18:268-274
23. Itano N, Sawai T, Atsumi F, Miyaishi O, Taniguchi S, Kannagi R, Hamaguchi M, Kimata K (2004) Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation. J Biol Chem 279:18679-18687
24. Ichikawa T, Itano N, Sawai T, Kimata K, Koganehira Y, Saida T, Taniguchi S (1999) Increased synthesis of hyaluronate enhances motility of human melanoma cells. J Invest Dermatol 113:935-939
25. Karousou E, Kamiryo M, Skandalis SS, Ruusala A, Asteriou T, Passi A, Yamashita H, Hellman U, Heldin CH, Heldin P (2010) The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination. J Biol Chem 285:23647-23654
26. Petersen O, Nielsen H, Gudjonsson T, Villadsen R, Rank F, Niebuhr E, Bissell M, Ronnov-Jessen L (2003) Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am J Pathol 162:391-402
27. Zoltan-Jones A, Huang L, Ghatak S, Toole B (2003) Elevated hyaluronan production induces mesenchymal and transformed properties in epithelial cells. J Biol Chem 278:45801-45810
28. Porsch H, Bernert B, Mehic M, Theocharis A, Heldin C, Heldin P (2012) Efficient TGFbeta-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2. Oncogene 32(37):4355-4365
29. Koyama H, Hibi T, Isogai Z, Yoneda M, Fujimori M, Amano J, Kawakubo M, Kannagi R, Kimata K, Taniguchi S, Itano N (2007) Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am J Pathol 170:1086-1099
30. Rilla K, Oikari S, Jokela TA, Hyttinen J, Kärnä R, Tammi R, Tammi M (2013) Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3. J Biol Chem 288:5973-5983
31. Vigetti D, Deleonibus S, Moretto P, Karousou E, Viola M, Bartolini B, Hascall V, Tammi M, De Luca G, Passi A (2012) Role of UDP-N-acetylglucosamine (GlcNAc) and O-GlcNAcylation of hyaluronan synthase 2 in the control of chondroitin sulfate and hyaluronan synthesis. J Biol Chem 287:35544-35555
32. van den Brandt P, Spiegelman D, Yaun S, Adami H, Beeson L, Folsom A, Fraser G, Goldbohm R, Graham S, Kushi L, Marshall J, Miller A, Rohan T, Smith-Warner S, Speizer F, Willett W, Wolk A, Hunter D (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152:514-527
33. Contiero P, Berrino F, Tagliabue G, Mastroianni A, Di Mauro M, Fabiano S, Annulli M, Muti P (2013) Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study. Breast Cancer Res Treat 138:951-959
34. Varadi T, Mersich T, Auvinen P, Tammi R, Tammi M, Salamon F, Besznyak I Jr, Jakab F, Baranyai Z, Szollosi J, Nagy P (2012) Binding of trastuzumab to ErbB2 is inhibited by a high pericellular density of hyaluronan. J Histochem Cytochem 60:567-575
35. Hascall V, Majors A, De La Motte C, Evanko S, Wang A, Drazba JA, Strong S, Wight T (2004) Intracellular hyaluronan: a new frontier for inflammation? Biochim Biophys Acta 1673:3-12
36. Toole B (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528-539
37. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436-444
38. Baek J, Jin Q, Ensor J, Boulbes D, Esteva F (2011) Serum CD44 levels and overall survival in patients with HER2-positive breast cancer. Breast Cancer Res Treat 130:1029-1036
39. Urakawa H, Nishida Y, Wasa J, Arai E, Zhuo L, Kimata K, Kozawa E, Futamura N, Ishiguro N (2012) Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo. Int J Cancer 130:454-466